Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico M Wulffraat

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Pediatric Rheumatology Online Journal|April 18, 2020
Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?Casper G Schoemaker, Joost F Swart, Nico M Wulffraat
Expert Opinion on Biological Therapy|October 29, 2010
The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritisJoost Frans Swart, Daantje Barug, Michelle Möhlmann, et al.
European Journal of Dermatology : EJD|November 11, 2005
The skin in primary immunodeficiency disordersJ Henk Sillevis Smitt, Nico M Wulffraat, Taco W Kuijpers
Pediatric Rheumatology Online Journal|August 9, 2022
Feasibility of quantitative sensory testing in juvenile idiopathic arthritisMaarten O Mensink, Niels Eijkelkamp, Dieuwke S Veldhuijzen, et al.
Best Practice & Research. Clinical Haematology|August 11, 2004
Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritisNico M Wulffraat, Ismee M de Kleer, Berent J Prakken, et al.
Expert Review of Clinical Immunology|August 25, 2018
The role of placebo effects in immune-related conditions: mechanisms and clinical considerationsRosanne M Smits, Dieuwke S Veldhuijzen, Nico M Wulffraat, et al.
Joint Bone Spine|February 11, 2004
Clostridium difficile-associated reactive arthritis in two childrenHelga A Löffler, Benedicte Pron, Richard Mouy, et al.
Annals of the Rheumatic Diseases|November 16, 2017
Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritisJoost F Swart, E H Pieter van Dijkhuizen, Nico M Wulffraat, et al.
Arthritis Care & Research|August 29, 2015
Prevalence of Severe Fatigue Among Adolescents With Pediatric Rheumatic DiseasesLinde N Nijhof, Elise M van de Putte, Nico M Wulffraat, et al.
Annals of the Rheumatic Diseases|December 17, 2011
Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional studyMarloes W Heijstek, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Pediatric Rheumatology Online Journal|April 18, 2020
Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?Casper G Schoemaker, Joost F Swart, Nico M Wulffraat
Expert Opinion on Biological Therapy|October 29, 2010
The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritisJoost Frans Swart, Daantje Barug, Michelle Möhlmann, et al.
European Journal of Dermatology : EJD|November 11, 2005
The skin in primary immunodeficiency disordersJ Henk Sillevis Smitt, Nico M Wulffraat, Taco W Kuijpers
Pediatric Rheumatology Online Journal|August 9, 2022
Feasibility of quantitative sensory testing in juvenile idiopathic arthritisMaarten O Mensink, Niels Eijkelkamp, Dieuwke S Veldhuijzen, et al.
Best Practice & Research. Clinical Haematology|August 11, 2004
Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritisNico M Wulffraat, Ismee M de Kleer, Berent J Prakken, et al.
Expert Review of Clinical Immunology|August 25, 2018
The role of placebo effects in immune-related conditions: mechanisms and clinical considerationsRosanne M Smits, Dieuwke S Veldhuijzen, Nico M Wulffraat, et al.
Joint Bone Spine|February 11, 2004
Clostridium difficile-associated reactive arthritis in two childrenHelga A Löffler, Benedicte Pron, Richard Mouy, et al.
Annals of the Rheumatic Diseases|November 16, 2017
Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritisJoost F Swart, E H Pieter van Dijkhuizen, Nico M Wulffraat, et al.
Arthritis Care & Research|August 29, 2015
Prevalence of Severe Fatigue Among Adolescents With Pediatric Rheumatic DiseasesLinde N Nijhof, Elise M van de Putte, Nico M Wulffraat, et al.
Annals of the Rheumatic Diseases|December 17, 2011
Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional studyMarloes W Heijstek, Pieter G M van Gageldonk, Guy A M Berbers, et al.
Pageof 15